Hirai H, Tanaka K, Yoshie O, Ogawa K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S. & Nagata K.
J. Exp. Med., 193, 255-261, 2001.
Huang Y-P, Ohtani K, Iwanaga R, Matsumura Y. & Nakamura M.
Oncogene, 20, 1094-1102, 2001.
Takasawa N, Ishii N, Higashimura N, Murata K, Tanaka Y, Nakamura M, Sasaki T. & Sugamura K.
Expression of gp34 (OX40 ligand) and OX40 on human T cell.
Jap. J. Cancer Res., 92, 377-382, 2001.
Iwanaga R, Ohtani K, Hayashi T, Kumamoto Y. & Nakamura M.
Oncogene, 20, 2055-2067, 2001.
Ogawa K, Tanaka K, Ishii A, Nakamura Y, Kondo S, Sugamura K, Takano S, Nakamura M, Nagata K.
A novel serum protein that is selectively produced by cytotoxic lymphocytes.
J. Immunol., 166, 6404-6412, 2001.
Takahashi Y, Tanaka Y, Yamashita A, Koyannagi Y, Nakamura M, Yamamoto N.
OX40 stimulation by gp34/OX40 ligand enhances productive HIV infection.
J. Virol., 75, 6748-6757, 2001.
Funato N, Ohtani K, Ohyama M, Kuroda T, Nakamura, M.
Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors.
Mol. Cell. Biol., 21, 7391-7402, 2001.
Tullio A, Bridgman PC, Tresser NJ, Chan C, Conti MA, Adelstein RS, Hara Y.
J. Comp. Neurol., 433, 62-74, 2001.